Legal Representation
Attorney
Nicholas D. Wells
USPTO Deadlines
Next Deadline
497 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20210601)
Due Date
June 01, 2027
Grace Period Ends
December 01, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
24 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 25, 2021 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Sep 24, 2021 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Sep 24, 2021 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Sep 1, 2021 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jun 1, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 16, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 16, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 15, 2021 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Feb 24, 2021 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Feb 24, 2021 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Feb 24, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 11, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 10, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 9, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 9, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 27, 2020 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Sep 7, 2020 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Sep 3, 2020 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Aug 7, 2020 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Aug 4, 2020 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Aug 3, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 3, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 3, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 30, 2020 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 009
Downloadable and recorded computer software, namely, a computer program for the treatment of breast cancer for use in strengthening and supporting the human immune system; downloadable and recorded computer software for use in viewing medical information and content in the nature of medical analysis and medical data; downloadable and recorded computer software for viewing scientific content in the nature of medical research; downloadable and recorded computer software, namely, interactive software for patients and medical professionals for the treatment of breast cancer
First Use Anywhere:
0
First Use in Commerce:
0
Class 041
Education, namely, conducting classes, seminars, conferences and workshops in the medical field utilizing software programs; training of users in the medical field in the use of digital treatment technology utilizing software programs; entertainment by means of a dialog-based communication system, namely, providing online video games; continuing training of patients and medical professionals in the field of breast cancer regarding strengthening and supporting the immune system
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Creation and development of computer programs for semantic networking and presentation of scientific data as well as for dialogue; technological services, namely, installation, maintenance and updated of computer software; creation of computer programs including artificial intelligence; medical research services
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Medical services for the computer-based interactive treatment support of patients and medical professionals in the field of breast cancer, namely, by strengthening and supporting the human immune system
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
009
041
042
044